Mouse CEA(Carcinoembryonic Antigen) ELISA Kit
To Order Contact us: [email protected]
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 438 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RDR-CEA-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 600 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 420 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
RD-CEA-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 574.8 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
20-abx153807 |
Abbexa |
-
EUR 6768.00
-
EUR 3610.80
-
EUR 848.40
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
abx053218-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
abx255256-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4138.42 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 445.99 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 585.7 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Mu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2275.63 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
4-SEA150Mu |
Cloud-Clone |
-
EUR 4198.80
-
EUR 2216.40
-
EUR 586.80
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Mouse Carcinoembryonic Antigen ELISA Kit (CEA) |
RK02678 |
Abclonal |
96 Tests |
EUR 625.2 |
Carcinoembryonic Antigen (CEA) (Mouse) ELISA Kit |
E4741-100 |
Biovision |
each |
EUR 966 |
Carcinoembryonic Antigen (CEA) |
MO47049 |
Neuromics |
0.5 ml |
EUR 418.8 |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
E-EL-M0232 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Mouse CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
ELK1130 |
ELK Biotech |
1 plate of 96 wells |
EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
Mouse Carcinoembryonic Antigen (CEA) CLIA Kit |
20-abx491146 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Mouse Carcinoembryonic Antigen (CEA) Protein |
20-abx065720 |
Abbexa |
-
EUR 828.00
-
EUR 343.20
-
EUR 2532.00
-
EUR 978.00
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Carcinoembryonic Antigen (CEA) Protein |
20-abx065722 |
Abbexa |
-
EUR 811.20
-
EUR 343.20
-
EUR 2498.40
-
EUR 961.20
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human carcinoembryonic antigen, CEA ELISA Kit |
CSB-E04767h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human carcinoembryonic antigen, CEA ELISA Kit |
1-CSB-E04767h |
Cusabio |
-
EUR 667.20
-
EUR 4634.40
-
EUR 2472.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
20-abx155329 |
Abbexa |
-
EUR 7087.20
-
EUR 3780.00
-
EUR 886.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
20-abx151022 |
Abbexa |
-
EUR 6373.20
-
EUR 3404.40
-
EUR 801.60
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Chicken Carcinoembryonic Antigen (CEA) ELISA Kit |
abx356418-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rabbit Carcinoembryonic Antigen (CEA) ELISA Kit |
abx362811-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Sheep Carcinoembryonic Antigen (CEA) ELISA Kit |
abx364185-96tests |
Abbexa |
96 tests |
EUR 1111.2 |
|
Monkey Carcinoembryonic Antigen (CEA) ELISA Kit |
abx359529-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Pig Carcinoembryonic Antigen (CEA) ELISA Kit |
abx361295-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
abx256792-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
abx250227-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
LF-EK60048 |
Abfrontier |
1×96T |
EUR 814.8 |
Human CEA(Carcinoembryonic Antigen) ELISA Kit |
EH0090 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
Carcinoembryonic Antigen (CEA) (human) ELISA Kit |
K4805-100 |
Biovision |
100 assays |
EUR 970.8 |
|
Description: Sensitive, Colorimetric Assay |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
PRB-5059 |
Cell Biolabs |
96 assays |
EUR 686.4 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
PRB-5059-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2739.6 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 3470.83 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 391.01 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 507.16 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 1922.21 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
4-SEA150Hu |
Cloud-Clone |
-
EUR 3531.60
-
EUR 1862.40
-
EUR 507.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4358.33 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 464.1 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 611.57 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
SEA150Ra-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2392.06 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
4-SEA150Ra |
Cloud-Clone |
-
EUR 4418.40
-
EUR 2332.80
-
EUR 612.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Carcinoembryonic Antigen ELISA Kit (CEA) |
RK01085 |
Abclonal |
96 Tests |
EUR 625.2 |
Rat Carcinoembryonic Antigen ELISA Kit (CEA) |
RK03562 |
Abclonal |
96 Tests |
EUR 625.2 |
Carcinoembryonic Antigen (CEA) (Human) ELISA Kit |
E4740-100 |
Biovision |
each |
EUR 966 |
Carcinoembryonic Antigen (CEA) (Rat) ELISA Kit |
E4742-100 |
Biovision |
each |
EUR 836.4 |
Human carcinoembryonic antigen (CEA) antigen |
CEA15-N-100 |
Alpha Diagnostics |
100 ug |
EUR 270 |
Human Carcinoembryonic Antigen (CEA) ELISA |
LF-EK0161 |
Abfrontier |
1×96T |
EUR 723.6 |
Eukaryotic Carcinoembryonic Antigen (CEA) |
4-EPA150Hu61 |
Cloud-Clone |
-
EUR 614.59
-
EUR 288.00
-
EUR 1974.72
-
EUR 738.24
-
EUR 1356.48
-
EUR 487.20
-
EUR 4756.80
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: 293F cell |
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102321 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102322 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102323 |
Abbexa |
-
EUR 393.60
-
EUR 159.60
-
EUR 1095.60
-
EUR 560.40
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx102324 |
Abbexa |
-
EUR 393.60
-
EUR 159.60
-
EUR 1095.60
-
EUR 560.40
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx171571 |
Abbexa |
|
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx171572 |
Abbexa |
|
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx175703 |
Abbexa |
-
EUR 410.40
-
EUR 159.60
-
EUR 1144.80
-
EUR 577.20
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
abx120020-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx128498 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx128499 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 944.40
-
EUR 493.20
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020536-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020540-1mg |
Abbexa |
1 mg |
EUR 944.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020541-1mg |
Abbexa |
1 mg |
EUR 910.8 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020542-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020543-1mg |
Abbexa |
1 mg |
EUR 886.8 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020544-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020545-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx020546-1mg |
Abbexa |
1 mg |
EUR 828 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx022526-01ml |
Abbexa |
0.1 ml |
EUR 1328.4 |
|
Carcinoembryonic Antigen (CEA) Antibody |
abx231576-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx270133 |
Abbexa |
-
EUR 560.40
-
EUR 644.40
-
EUR 326.40
-
EUR 978.00
-
EUR 427.20
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx270165 |
Abbexa |
-
EUR 560.40
-
EUR 644.40
-
EUR 326.40
-
EUR 978.00
-
EUR 427.20
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody |
20-abx270190 |
Abbexa |
-
EUR 560.40
-
EUR 644.40
-
EUR 326.40
-
EUR 978.00
-
EUR 427.20
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Active Carcinoembryonic Antigen (CEA) |
4-APA150Hu04 |
Cloud-Clone |
-
EUR 778.02
-
EUR 331.20
-
EUR 2587.58
-
EUR 942.53
-
EUR 1765.06
-
EUR 596.40
-
EUR 6288.96
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Hu01 |
Cloud-Clone |
-
EUR 485.57
-
EUR 253.20
-
EUR 1490.88
-
EUR 576.96
-
EUR 1033.92
-
EUR 400.80
-
EUR 3547.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Hu02 |
Cloud-Clone |
-
EUR 485.57
-
EUR 253.20
-
EUR 1490.88
-
EUR 576.96
-
EUR 1033.92
-
EUR 400.80
-
EUR 3547.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Hu03 |
Cloud-Clone |
-
EUR 485.57
-
EUR 253.20
-
EUR 1490.88
-
EUR 576.96
-
EUR 1033.92
-
EUR 400.80
-
EUR 3547.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Hu04 |
Cloud-Clone |
-
EUR 485.57
-
EUR 253.20
-
EUR 1490.88
-
EUR 576.96
-
EUR 1033.92
-
EUR 400.80
-
EUR 3547.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Mu01 |
Cloud-Clone |
-
EUR 588.79
-
EUR 280.80
-
EUR 1877.95
-
EUR 705.98
-
EUR 1291.97
-
EUR 469.20
-
EUR 4514.88
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Mu02 |
Cloud-Clone |
-
EUR 582.34
-
EUR 279.60
-
EUR 1853.76
-
EUR 697.92
-
EUR 1275.84
-
EUR 465.60
-
EUR 4454.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli |
Recombinant Carcinoembryonic Antigen (CEA) |
4-RPA150Ra01 |
Cloud-Clone |
-
EUR 599.54
-
EUR 283.20
-
EUR 1918.27
-
EUR 719.42
-
EUR 1318.85
-
EUR 476.40
-
EUR 4615.68
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Carcinoembryonic Antigen expressed in: E.coli |
CEA Antibody / Carcinoembryonic Antigen |
RQ5159 |
NSJ Bioreagents |
100ul |
EUR 419 |
CEA Antibody / Carcinoembryonic Antigen |
V8370-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
CEA Antibody / Carcinoembryonic Antigen |
V8370-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
CEA Antibody / Carcinoembryonic Antigen |
V8370SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
CEA Antibody / Carcinoembryonic Antigen |
V2087-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2087-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2087IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2087SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2088-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2088-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2088IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2088SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2089-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2089-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2089IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2089SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2375-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2375-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2375IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2375SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2376-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2376-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2376CF488-100T |
NSJ Bioreagents |
100 Tests |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2376IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2376SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3716-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3716SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V7069-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V7069-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V7069IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V7069SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
CEA Antibody / Carcinoembryonic Antigen |
V2444-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2444-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2444IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2444SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2445-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2445-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2445SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2446-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2446-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2446IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2446SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2447-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2447-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2447IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V2447SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3527-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3527-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3527SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3597SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V3598-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3598-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3598IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3598SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V3599SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
CEA Antibody / Carcinoembryonic Antigen |
V8631-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
CEA Antibody / Carcinoembryonic Antigen |
V8631-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
CEA Antibody / Carcinoembryonic Antigen |
V8631SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
CEA Antibody / Carcinoembryonic Antigen |
V8890-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V8890-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V8890SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9002SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9003SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9008SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9164-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9164-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9164SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9318-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9318-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V9318SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V4046-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V4046-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
CEA Antibody / Carcinoembryonic Antigen |
V4046SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
Carcinoembryonic Antigen(CEA) Mouse Monoclonal Antibody |
38016-100ul |
SAB |
100ul |
EUR 302.4 |
Carcinoembryonic Antigen(CEA) Mouse Monoclonal Antibody |
38016-50ul |
SAB |
50ul |
EUR 224.4 |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse) |
4-PAA150Mu01 |
Cloud-Clone |
-
EUR 246.00
-
EUR 2235.60
-
EUR 573.60
-
EUR 301.20
-
EUR 235.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA) |
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
E-EL-H0643 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
E-EL-R0150 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
ELK1297 |
ELK Biotech |
1 plate of 96 wells |
EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
ELISA kit for Human carcinoembryonic antigen,CEA |
EK0179 |
SAB |
96 tests |
EUR 794.4 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human carcinoembryonic antigen,CEA in samples from serum, plasma, tissue homogenates and other biological fluids. |
Human Carcinoembryonic Antigen (CEA) OneStep ELISA Kit |
EK7031 |
BosterBio |
96wells/kit, with removable strips. |
EUR 573.6 |
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
ELK1196 |
ELK Biotech |
1 plate of 96 wells |
EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
CEA ELISA Kit| Rat Carcinoembryonic Antigen ELISA Kit |
EF017615 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Human Carcinoembryonic Antigen (CEA) ELISA (4X96T) |
LF-EK0162 |
Abfrontier |
4×96T |
EUR 2454 |
Human Carcinoembryonic Antigen (CEA) ELISA (10X96T) |
LF-EK0163 |
Abfrontier |
10×96T |
EUR 5380.8 |
Human Carcinoembryonic Antigen (CEA) ELISA (20X96T) |
LF-EK0164 |
Abfrontier |
20×96T |
EUR 9369.6 |
Human Carcinoembryonic Antigen (CEA) CLIA Kit |
abx196501-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rat Carcinoembryonic Antigen (CEA) CLIA Kit |
abx196777-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human Carcinoembryonic Antigen (CEA) CLIA Kit |
20-abx491145 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Rat Carcinoembryonic Antigen (CEA) CLIA Kit |
20-abx491147 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Carcinoembryonic Antigen/CEA Monoclonal Antibody |
EM1061-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Mouse Monoclonal antibody against Carcinoembryonic Antigen/CEA from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
Carcinoembryonic Antigen/CEA Monoclonal Antibody |
EM1061-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Mouse Monoclonal antibody against Carcinoembryonic Antigen/CEA from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
Human Carcinoembryonic Antigen (CEA) Protein |
20-abx166414 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2013.60
-
EUR 811.20
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
20-abx065719 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2013.60
-
EUR 811.20
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
20-abx065721 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2013.60
-
EUR 811.20
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
20-abx065723 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2013.60
-
EUR 811.20
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody Pair |
20-abx370130 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
20-abx651474 |
Abbexa |
-
EUR 861.60
-
EUR 343.20
-
EUR 2665.20
-
EUR 1028.40
-
EUR 610.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Carcinoembryonic Antigen (CEA) Protein |
20-abx652080 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2581.20
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
20-abx270431 |
Abbexa |
-
EUR 627.60
-
EUR 727.20
-
EUR 360.00
-
EUR 1128.00
-
EUR 460.80
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
20-abx270463 |
Abbexa |
-
EUR 627.60
-
EUR 727.20
-
EUR 360.00
-
EUR 1128.00
-
EUR 460.80
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
20-abx270488 |
Abbexa |
-
EUR 627.60
-
EUR 727.20
-
EUR 360.00
-
EUR 1128.00
-
EUR 460.80
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
20-abx270663 |
Abbexa |
-
EUR 844.80
-
EUR 994.80
-
EUR 444.00
-
EUR 1596.00
-
EUR 594.00
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
20-abx270695 |
Abbexa |
-
EUR 844.80
-
EUR 994.80
-
EUR 444.00
-
EUR 1596.00
-
EUR 594.00
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
20-abx270720 |
Abbexa |
-
EUR 844.80
-
EUR 994.80
-
EUR 444.00
-
EUR 1596.00
-
EUR 594.00
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
20-abx270895 |
Abbexa |
-
EUR 727.20
-
EUR 861.60
-
EUR 393.60
-
EUR 1362.00
-
EUR 526.80
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
20-abx270927 |
Abbexa |
-
EUR 727.20
-
EUR 861.60
-
EUR 393.60
-
EUR 1362.00
-
EUR 526.80
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
20-abx270952 |
Abbexa |
-
EUR 727.20
-
EUR 861.60
-
EUR 393.60
-
EUR 1362.00
-
EUR 526.80
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Carcinoembryonic Antigen (CEA) Antibody (Biotin) |
20-abx271833 |
Abbexa |
-
EUR 376.80
-
EUR 260.40
-
EUR 1028.40
-
EUR 526.80
-
EUR 326.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Antibody (Biotin) |
20-abx272619 |
Abbexa |
-
EUR 410.40
-
EUR 260.40
-
EUR 1195.20
-
EUR 594.00
-
EUR 360.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
anti-Carcinoembryonic Antigen/CEA (10E1) |
LF-MA20354 |
Abfrontier |
100 ug |
EUR 424.8 |
Description: Mouse monoclonal to Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), APC |
4-PAA150Mu01-APC |
Cloud-Clone |
-
EUR 339.60
-
EUR 2871.60
-
EUR 830.40
-
EUR 421.20
-
EUR 231.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with APC. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), Biotinylated |
4-PAA150Mu01-Biotin |
Cloud-Clone |
-
EUR 319.20
-
EUR 2175.60
-
EUR 678.00
-
EUR 379.20
-
EUR 240.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Biotin. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), Cy3 |
4-PAA150Mu01-Cy3 |
Cloud-Clone |
-
EUR 403.20
-
EUR 3778.80
-
EUR 1057.20
-
EUR 512.40
-
EUR 259.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Cy3. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), FITC |
4-PAA150Mu01-FITC |
Cloud-Clone |
-
EUR 295.20
-
EUR 2320.80
-
EUR 687.60
-
EUR 361.20
-
EUR 208.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with FITC. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), HRP |
4-PAA150Mu01-HRP |
Cloud-Clone |
-
EUR 314.40
-
EUR 2508.00
-
EUR 739.20
-
EUR 385.20
-
EUR 220.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with HRP. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), PE |
4-PAA150Mu01-PE |
Cloud-Clone |
-
EUR 295.20
-
EUR 2320.80
-
EUR 687.60
-
EUR 361.20
-
EUR 208.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with PE. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse) |
4-PAA150Mu02 |
Cloud-Clone |
-
EUR 246.00
-
EUR 2235.60
-
EUR 573.60
-
EUR 301.20
-
EUR 235.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse) |
4-PAA150Hu04 |
Cloud-Clone |
-
EUR 225.60
-
EUR 1903.20
-
EUR 498.00
-
EUR 271.20
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA) |
CLIA kit for Human CEA (Carcinoembryonic Antigen) |
E-CL-H0492 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
CLIA kit for Rat CEA (Carcinoembryonic Antigen) |
E-CL-R0108 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
Mouse carcinoembryonic antign, CEA ELISA Kit |
CSB-E13925m-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse carcinoembryonic antign, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Mouse carcinoembryonic antign, CEA ELISA Kit |
1-CSB-E13925m |
Cusabio |
-
EUR 1080.00
-
EUR 6571.20
-
EUR 3480.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse carcinoembryonic antign, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse CEA(Carcinoembryonic Antign) ELISA Kit |
EM0916 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 37.5pg/ml |
Mouse carcinoembryonic antign(CEA)ELISA Kit |
GA-E0111MS-48T |
GenAsia Biotech |
48T |
EUR 403.2 |
Mouse carcinoembryonic antign(CEA)ELISA Kit |
GA-E0111MS-96T |
GenAsia Biotech |
96T |
EUR 640.8 |
Human Carcinoembryonic Antigen (CEA) Protein (Active) |
20-abx655572 |
Abbexa |
-
EUR 1345.20
-
EUR 493.20
-
EUR 4468.80
-
EUR 1629.60
-
EUR 910.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Rat) |
4-PAA150Hu01 |
Cloud-Clone |
-
EUR 225.60
-
EUR 1903.20
-
EUR 498.00
-
EUR 271.20
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human) |
4-PAA150Hu02 |
Cloud-Clone |
-
EUR 225.60
-
EUR 1903.20
-
EUR 498.00
-
EUR 271.20
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human) |
4-PAA150Hu03 |
Cloud-Clone |
-
EUR 225.60
-
EUR 1903.20
-
EUR 498.00
-
EUR 271.20
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Carcinoembryonic Antigen (CEA) |
Carcinoembryonic Antigen (CEA) ELISA Kit (Human) : 96 Wells (OKBA00007) |
OKBA00007 |
Aviva Systems Biology |
96 Wells |
EUR 396 |
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: 1.0 ng/ml |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), HRP |
4-PAA150Hu04-HRP |
Cloud-Clone |
-
EUR 286.80
-
EUR 2115.60
-
EUR 640.80
-
EUR 345.60
-
EUR 208.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with HRP. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), PE |
4-PAA150Hu04-PE |
Cloud-Clone |
-
EUR 270.00
-
EUR 1958.40
-
EUR 597.60
-
EUR 325.20
-
EUR 198.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with PE. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), APC-Cy7 |
4-PAA150Mu01-APC-Cy7 |
Cloud-Clone |
-
EUR 535.20
-
EUR 5599.20
-
EUR 1516.80
-
EUR 699.60
-
EUR 319.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with APC-Cy7. |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), APC |
4-PAA150Mu02-APC |
Cloud-Clone |
|